Why Tungsten?
Team
TransactionS
Portfolio
News
Contact US
Transactions
Successful track record of originating and executing transactions
Our Capabilities
Financings:
Private Placement (PP)
Private Investment in Public Equity (PIPE)
Registered Direct (RD)
Confidentially Marketed Public Offering (CMPO)
Equity Line of Credit (ELOC)
Licensing:
Inward Corporate Licensing (ICL) of Global and Regional Rights
Outward Corporate Licensing (OCL) of Global and Regional Rights
Mergers & Acquisitions:
Acquisitions
Divestments including Spin-Offs, Split-Offs, Carve-Outs, Asset Sales
Strategic Mergers including Reverse Mergers
Special Purpose Acquisition Corp (SPAC) Mergers
Our Transactions
FILTER BY
Financings
Licensing
M&A
Outward US License of Proclarix® to
licensing
Equity Financing of Prognos Health led by
financings
Equity Financing of MolecuLight led by
financings
Equity Financing of MFS Corp led by
financings
Divestment of VCN Biosciences to
m&a
Debt Financing of Moleculight led by
financings
Equity Financing of iPill led by
financings
Divestment of Sandstone Diagnostics to
m&a
Equity Financing of Breonics led by
financings
Divestment of INUI Health to
m&a
Inward Global License of KIN-001 from
licensing
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Have a lightbulb moment with us
Sign up for updates from Tungsten
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Have a lightbulb moment with us
Sign up for updates from Tungsten
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.